Overview
Portfolio
More
Arben Ventures
Arben Ventures backs early‑stage deep‑tech health startups that are redefining personalized medicine through precision medicine, multi‑omics and innovative medical devices. The firm focuses on areas such as early cancer...
Portfolio
69+
Employees
10+
Founded
2022
AUM
≈ $0.0
Investment focus
Stages
Pre-Seed → Seed
Industries
BiotechnologyDigital HealthMedical DevicesWellness & Fitness Technology
Geographic scope
United States
Fund details
Check sizes
Min: $25.0K
Typical: $50.0K
Max: $500.0K
Sources
Arben Ventures
Arben Ventures backs early‑stage deep‑tech health startups that are redefining personalized medicine through precision medicine, multi‑omics and innovative medical devices. The firm focuses on areas such as early cancer detection, women’s health, mental health and longevity, seeking founders at the intersection of biology and technology. By providing $25‑50K initial checks (up to $500K follow‑on), Arben aims to accelerate breakthroughs that improve global health outcomes.
Portfolio
69+
Employees
10+
Founded
2022
AUM
≈ $0.0
Check Sizes
Min: $25.0K
Typical: $50.0K
Max: $500.0K
Stages
Pre-Seed → Seed
Industries
BiotechnologyDigital HealthMedical DevicesWellness & Fitness Technology
Geographic scope
United States
Sources
Showing 24 of 59 matched portfolio companies
Abe Health provides an AI-powered assistant for nutritionists, trainers, and coaches that analyzes client data and delivers personalized, actionable advice. This enables wellness professionals to scale their practice by reducing time spent per client while maximizing the impact on their health and wellness.
The startup provides a platform that utilizes advanced data analytics and machine learning algorithms to convert complex patient data into actionable insights for healthcare providers. This enables medical professionals to deliver targeted and timely care, improving patient outcomes and operational efficiency.
Alden Scientific combines artificial intelligence with extensive biological data to create a detailed, individualized health profile for users. This approach enables individuals and healthcare providers to predict and manage health conditions more effectively, enhancing personalized care and treatment options.
Allia Health utilizes AI-driven analytics and machine learning to enhance mental healthcare by streamlining patient intake, clinical documentation, and treatment planning. The platform addresses inefficiencies in mental health practices, enabling providers to focus more on patient care while delivering data-driven insights for improved treatment outcomes.
Terra is an automatic cooling system designed to provide relief from hot flashes during sleep. It uses a bracelet sensor to predict flashes and instantly circulates chilled water through a mattress pad for proactive temperature regulation. This system promotes uninterrupted sleep, leading to improved energy and overall well-being.
Funding: $2.6M
Rough estimate of the amount of funding raised
Funding: $2.6M
Rough estimate of the amount of funding raised
The startup offers an omnichannel fixed yield platform that provides secure access to decentralized finance through cross-collateralized margin accounts, built-in clearing, and reporting. This enables clients to achieve diversified yield exposure while enhancing capital efficiency in the digital economy.
BeSound Breast provides advanced, radiation-free ultrasound imaging for enhanced breast cancer detection, particularly effective for dense breast tissue. This technology offers a comfortable, 20-minute scan experience with AI-powered analysis and results delivered within 48 hours. The service aims to improve early detection rates, offering a modern alternative to traditional mammography.
5+
500+Approximate amount of employees
Funding: $6.8M
Rough estimate of the amount of funding raised
Funding: $6.8M
Rough estimate of the amount of funding raised
Bexson Biomedical is developing a subcutaneous delivery system for its BB106 non-opioid therapy, targeting acute pain management to provide an alternative to opioids. The company's formulation platform enhances the pharmacokinetics of existing drugs, enabling effective home health delivery and addressing the challenges of pain treatment without the risks associated with opioid use.
Funding: $12.8M
Rough estimate of the amount of funding raised
Funding: $12.8M
Rough estimate of the amount of funding raised
This company develops a novel platform for drug formulation and dose preparation by integrating microfluidics manufacturing, robotics, and AI. The platform addresses the scaling challenges associated with complex next-generation and curative therapies. This technology aims to accelerate the transition to curative medicine and improve patient access.
Funding: $500.0K
Rough estimate of the amount of funding raised
Funding: $500.0K
Rough estimate of the amount of funding raised
This company develops small molecules and AI-driven platforms to enhance biomanufacturing processes across various modalities. Their technology boosts T cell expansion for therapeutics and optimizes host cell productivity for recombinant protein and AAV production. They offer on-demand access to their virtual cell modeling platform to rapidly generate and refine molecules for improved yield and quality.
This startup develops mental healthcare drugs and therapies focused on cognitive neuro-engineering. Their treatments aim to enhance desirable cognitive traits like mindfulness and mental acuity, helping individuals manage conditions such as stress, anxiety, and depression.
The startup develops real-time tuning technology for hearing aids, enabling users to adjust sound clarity and volume based on their immediate environment. This technology enhances the listening experience by allowing users to engage fully in conversations and enjoy various sounds at an accessible price point.
10+
7K+Approximate amount of employees
Funding: $9.1M
Rough estimate of the amount of funding raised
Funding: $9.1M
Rough estimate of the amount of funding raised
CureMetrix develops AI algorithms that enhance the detection of breast cancer and heart disease through advanced imaging analysis. Their technology increases diagnostic accuracy, facilitating earlier intervention and improving patient outcomes in healthcare settings worldwide.
This company develops automated, chip-based infrastructure to generate scalable and reliable biological datasets for training and testing predictive models. Their Bio-Server replaces manual wet-lab workflows with miniaturized, high-throughput experiments to overcome data quantity and consistency limitations in biological research. This approach accelerates discovery by providing model-ready data essential for advancing AI-driven drug discovery and computational biology.
The startup specializes in breath-based diagnostics that utilize gas chromatography and mass spectrometry to analyze volatile organic compounds in exhaled breath. This technology provides non-invasive health assessments, enabling early detection of respiratory and metabolic conditions.
EIGHT is a video-first platform that facilitates real-time, 8-minute live video interactions among verified users, creating a secure environment for authentic networking. By addressing the issues of catfishing and ghosting prevalent in traditional online communication, EIGHT enables users to form meaningful connections efficiently every evening at 8 PM.
Endo Health is developing a gamified AI medical assistant specifically designed for managing type 2 diabetes, providing personalized guidance and support throughout the patient's care journey. This platform enhances patient engagement and adherence to management protocols, ultimately improving health outcomes for individuals with diabetes.
Funding: $950.0K
Rough estimate of the amount of funding raised
Funding: $950.0K
Rough estimate of the amount of funding raised
Enovone provides virtual healthcare services focused on longevity-related conditions such as fatigue, anxiety, and weight management. Patients complete an online assessment and receive validation from board-certified doctors for personalized treatment plans, including medication. The service operates on transparent, out-of-pocket pricing and offers ongoing virtual support and regular treatment adjustments.
Expansion Technologies utilizes expansion microscopy, optogenetics, and high-speed brain activity imaging to create detailed computer simulations of the human brain. This approach aims to enhance our understanding of brain diseases and the underlying connectivity that informs artificial intelligence development.
Funding: $3.5M
Rough estimate of the amount of funding raised
Funding: $3.5M
Rough estimate of the amount of funding raised
Feminai develops a smart, wearable, disposable patch that enables women to conduct self-tests for breast lesion abnormalities at home, utilizing artificial intelligence for accurate detection. This technology addresses the challenge of early breast cancer diagnosis by providing a non-intrusive, affordable, and efficient screening method.
Feno has developed the Smartbrush, an AI-powered toothbrush that utilizes an oral scanner and a connected app to provide real-time analysis of oral health markers, enabling users to detect potential systemic health risks. By delivering a full-mouth clean in just 20 seconds and generating personalized health reports, Feno addresses the link between poor oral hygiene and serious diseases such as heart disease and cancer.
Funding: $6.0M
Rough estimate of the amount of funding raised
Funding: $6.0M
Rough estimate of the amount of funding raised
Genie develops a discovery platform leveraging machine learning and omics to identify novel molecular biomarkers for reproductive health. This platform powers a non-invasive diagnostic that analyzes molecular biomarkers in the uterine lining using menstrual blood. The company aims to improve fertility screening by providing data on endometrial health, a factor often overlooked in current fertility assessments.
Glyphic Biotechnologies develops Protein Sequencing by Expansion (ProSE™), a novel technology for high-throughput proteome sequencing. This method achieves single-molecule sensitivity for accurate discrimination of all 20 amino acids and post-translational modifications (PTMs). The platform aims to provide unprecedented precision and scalability for advancing proteomics research and therapeutic development.
Funding: $43.8M
Rough estimate of the amount of funding raised
Funding: $43.8M
Rough estimate of the amount of funding raised
Hertility Health offers a diagnostic Hormone and Fertility Test that provides clinical-grade results to assess hormonal health and fertility status, including insights into egg count and symptom management. The platform addresses the lack of tailored healthcare solutions for women by delivering personalized care plans and expert consultations for reproductive health issues.
Funding: $18.4M
Rough estimate of the amount of funding raised
Funding: $18.4M
Rough estimate of the amount of funding raised
Showing 10 of 10 unmatched portfolio companies